Calamos Wealth Management LLC Novo Nordisk A S Transaction History

Calamos Wealth Management LLC

$2.63 Billion
Q3 2025

A detailed history of Calamos Wealth Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Calamos Wealth Management LLC holds 7,482 shares of NVO stock, worth $362,577. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,482

Previous 7,067 5.87%

Holding current value

$362,577

Previous $487,000 14.78%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$45.38 - $71.7 $18,832 - $29,755	415 Added 5.87%	7,482 $415,000
Q2 2025 Jul 29, 2025	SELL	$58.08 - $81.05 $911,681 - $1.27 Million	-15,697 Reduced 68.96%	7,067 $487,000
Q1 2025 Apr 28, 2025	BUY	$69.3 - $90.95 $232,224 - $304,773	3,351 Added 17.26%	22,764 $1.58 Million
Q4 2024 Jan 24, 2025	SELL	$85.0 - $120.04 $998,070 - $1.41 Million	-11,742 Reduced 37.69%	19,413 $1.67 Million
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $2.23 Million - $2.72 Million	-18,712 Reduced 37.52%	31,155 $3.71 Million

Q2 2024 Jul 25, 2024	BUY	$122.71 - $146.91 $413,287 - $494,792	3,368 Added 7.24%	49,867 $7.12 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $94,553 - $125,861	926 Added 2.03%	46,499 $5.97 Million
Q4 2023 Jan 31, 2024	BUY	$87.78 - $105.45 $107,267 - $128,859	1,222 Added 2.76%	45,573 $4.71 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $2.07 Million - $4.55 Million	22,797 Added 105.77%	44,351 $4.03 Million
Q2 2023 Jul 28, 2023	SELL	$155.98 - $172.65 $55,684 - $61,636	-357 Reduced 1.63%	21,554 $3.49 Million
Q1 2023 May 03, 2023	SELL	$132.34 - $159.14 $669,640 - $805,248	-5,060 Reduced 18.76%	21,911 $3.49 Million
Q4 2022 Jan 25, 2023	SELL	$102.55 - $135.33 $85,424 - $112,729	-833 Reduced 3.0%	26,971 $0
Q3 2022 Oct 24, 2022	SELL	$95.28 - $116.93 $259,638 - $318,634	-2,725 Reduced 8.93%	27,804 $2.77 Million
Q2 2022 Aug 01, 2022	BUY	$103.24 - $121.81 $456,630 - $538,765	4,423 Added 16.94%	30,529 $3.4 Million
Q1 2022 May 03, 2022	BUY	$93.1 - $112.54 $114,513 - $138,424	1,230 Added 4.94%	26,106 $2.9 Million
Q4 2021 Feb 01, 2022	BUY	$95.88 - $117.08 $179,583 - $219,290	1,873 Added 8.14%	24,876 $2.79 Million
Q3 2021 Oct 26, 2021	BUY	$84.42 - $106.62 $36,975 - $46,699	438 Added 1.94%	23,003 $2.21 Million
Q2 2021 Jul 22, 2021	BUY	$67.66 - $84.76 $308,664 - $386,675	4,562 Added 25.34%	22,565 $1.89 Million
Q1 2021 Apr 12, 2021	BUY	$67.06 - $75.82 $129,090 - $145,953	1,925 Added 11.97%	18,003 $1.21 Million
Q4 2020 Jan 27, 2021	SELL	$63.89 - $73.8 $24,725 - $28,560	-387 Reduced 2.35%	16,078 $1.12 Million
Q3 2020 Oct 26, 2020	BUY	$63.69 - $70.22 $195,591 - $215,645	3,071 Added 22.93%	16,465 $1.14 Million
Q2 2020 Jul 27, 2020	BUY	$58.54 - $67.94 $221,866 - $257,492	3,790 Added 39.46%	13,394 $877,000
Q1 2020 Apr 28, 2020	BUY	$49.46 - $64.78 $475,013 - $622,147	9,604 New	9,604 $578,000

Others Institutions Holding NVO

# of Institutions

1,695

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.

Account

Calamos Wealth Management LLC Novo Nordisk A S Transaction History